Caribou Biosciences Vs. Arbutus Biopharma Industry Stock Comparison

Buy

67

CRBU
Caribou Biosciences

Last Price:

2.20

Seasonality Move:

-3.22%

Sell

40

ABUS
Arbutus Biopharma

Last Price:

3.66

Seasonality Move:

13.65%

Buy

67

Caribou Biosciences (CRBU) is a Buy

Is Caribou Biosciences a Buy, Sell or Hold?

The current Caribou Biosciences [CRBU] share price is $2.35. The Score for CRBU is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
CRBU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

40

Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

The current Arbutus Biopharma [ABUS] share price is $3.65. The Score for ABUS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRBU Stock Price Chart

What is Caribou Biosciences's stock price today?

The Caribou Biosciences share price today is $2.35
The current trend is moderately bearish and CRBU is experiencing selling pressure, which indicates risk of future bearish movement.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

The Arbutus Biopharma share price today is $3.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.

CRBU Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.19	Buy
Relative Strength Index (14 RSI):	54.29	Buy
Chaikin Money Flow:	-1507543	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.79 - 2.45)	Buy
Bollinger Bands (100):	(1.76 - 2.32)	Buy

ABUS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.06	Sell
Relative Strength Index (14 RSI):	36.42	Sell
Chaikin Money Flow:	-333283	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.78 - 4.08)	Sell
Bollinger Bands (100):	(3.47 - 4.15)	Sell

CRBU Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2.56	Sell
20-day SMA:	2.18	Buy
50-day SMA:	2.03	Buy
200-day SMA:	3.35	Sell
8-day EMA:	2.5	Sell
20-day EMA:	2.28	Buy
50-day EMA:	2.14	Buy
200-day EMA:	3.04	Sell

ABUS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.82	Sell
20-day SMA:	3.95	Sell
50-day SMA:	4.02	Sell
200-day SMA:	3.33	Buy
8-day EMA:	3.79	Sell
20-day EMA:	3.88	Sell
50-day EMA:	3.9	Sell
200-day EMA:	3.42	Buy

Caribou Biosciences Earnings Growth & CRBU Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.50 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Caribou Biosciences Technical Analysis

	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12
	Oct			Nov
	30	31	01	04	05	06	07	08	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12
	Oct			Nov
	30	31	01	04	05	06	07	08	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):